Commercial

Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients

May 23, 2017

PARIS and TARRYTOWN, N.Y., May 22, 2017 /PRNewswire/ — Sanofi and Regeneron Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) approval of Kevzara® (sarilumab) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more disease modifying […]

Benign Prostatic Hyperplasia Drugs Market Growing at a CAGR of 7.07% During 2017 to 2021, Says a New Report at ReportsnReports.com

May 22, 2017

PUNE, India, May 19, 2017 /PRNewswire/ —   Global Benign Prostatic Hyperplasia Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the present scenario and the growth prospects of the global benign prostatic hyperplasia drugs market for 2017-2021. To calculate the market size, the […]

Improving New Pharmaceutical Product Launch Results through Effective Preparation of District Sales Managers

May 22, 2017

CHAPEL HILL, N.C., May 19, 2017 /PRNewswire/ — While an effective sales force is integral to a successful product launch in the biopharmaceutical industry, it is the district sales manager who plays a key role in reps’ performance in the field.   Realizing this, savvy pharmaceutical companies are beginning to focus more attention on preparing […]

Kaposi Sarcoma Market Growing at a CAGR of 2.46% During 2017 to 2021 Says a New Report at ReportsnReports.com

May 22, 2017

PUNE, India, May 22, 2017 /PRNewswire/ — Global Kaposi Sarcoma Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the present scenario and the growth prospects of the global Kaposi sarcoma market for 2017-2021. To calculate the market size, the report considers the sales of […]

Teneobio and Poseida Announce License Agreement for the Use of UniDab™ in CAR T-Cell Therapy

May 22, 2017

MENLO PARK, Calif. and SAN DIEGO, May 22, 2017 (GLOBE NEWSWIRE) — Teneobio, Inc. and Poseida Therapeutics, Inc. today announced that they have entered a commercial license agreement for the use of Teneobio’s UniDabs™, single-domain, human heavy chain only antibodies in Chimeric Antigen Receptor (CAR) T-cell therapy. Under the terms of the agreement Poseida has […]

Virtual Engagement – a Must-have Component of any Pharmaceutical Sales Strategy

May 22, 2017

In this episode, Michael Carlin talks about how Virtual Engagements are addressing the issue of limited physician access by pharmaceutical reps, including keys to success, measuring results, and the degree of success with these programs. There is also a related white paper entitled, “Driving Greater Access to Healthcare Professionals and Increasing Brand Performance.” It can be downloaded using the […]

Driving Greater Access to Healthcare Professionals and Increasing Brand Performance

May 22, 2017

Virtual engagement strategies are evolving the way the pharmaceutical industry connects with key stakeholders. By using a blend of technology and experienced personnel to seamlessly connect brands to healthcare professionals, virtual engagement offers a solution to the trend of decreased in-person engagement opportunities via the traditional field representative model. This white paper examines how brands […]

New advanced therapy to repair cartilage defects in the knee

May 19, 2017

The European Medicines Agency (EMA) has recommended granting a marketing authorisation in the European Union (EU) for a new advanced therapy medicinal product (ATMP) to treat adult patients who have symptomatic articular cartilage defects in the femoral condyle (the ball-shaped end of the thigh bone in the knee) and the patella (knee cap), where the […]

New medicine for rare eye disease

May 19, 2017

The European Medicines Agency (EMA) has recommended granting a marketing authorisation in the European Union (EU) for Oxervate (cenegermin) for the treatment of moderate or severe neurotrophic keratitis, a rare eye disease that can lead to loss of sight. Patients with neurotrophic keratitis have damage to the trigeminal nerve (one of the nerves that supplies […]

Cardiometabolic Health Congress Announces New Senior Planning Committee

May 19, 2017

May 15, 2017 (Boca Raton, FL) – The Cardiometabolic Health Congress is excited to announce the members of the new Senior Planning Committee for the 2017 – 2018 CMHC educational curriculum: Drs. Deepak Bhatt, Keith Ferdinand, JoAnn Lindenfeld, and Clyde Yancy. Working in conjunction with the CMHC Chairpersons, the Senior Planning Committee will lead the […]

Improved Patient Outcomes and Financial Performance

May 18, 2017

Neither orphan drug manufacturers nor their patients with rare diseases are served well by the traditional multi-channel model of drug delivery and patient service. A new integrated model increases adherence and improves patient outcomes, which in turn leads to better financial performance for manufacturers.

Amazon is hiring people to break into the multibillion-dollar pharmacy market

May 18, 2017

For the last few years, Amazon has held at least one annual meeting at its Seattle headquarters to discuss whether it should enter the pharmacy business, says two people familiar with the company’s plans. But this year, with the rise of high-deductible plans and the trend toward consumers paying for health care, it is ready […]

Worldwide Clinical Trials Founder Neal Cutler, M.D., Honored With 2017 European CEO Award

May 18, 2017

Dr. Cutler recognized as “Best CEO in the CRO Industry,” for his leadership in pivotal clinical trials and success as a clinical researcher MORRISVILLE, NC, MAY 17, 2017 – Neal Cutler, M.D., Chief Executive Officer of Worldwide Clinical Trials (www.worldwide.com), has been named by the 2017 European CEO Awards as the “Best CEO in the […]

Sera Prognostics Appoints Nadia Altomare as Chief Commercial Officer

May 18, 2017

Sera Prognostics Appoints Nadia Altomare as Chief Commercial Officer SALT LAKE CITY, May 17, 2017– Sera Prognostics, Inc., a women’s healthcare company, announced today that Nadia F. Altomare has joined the company as chief commercial officer. Ms. Altomare will lead all commercial activities for Sera as the company makes its groundbreaking PreTRM® test available to […]

BioreclamationIVT Appoints Senior Marketing Communications Manager

May 18, 2017

BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it has appointed Lauren Vagnone as senior marketing communications manager. In this newly-created position, Ms. Vagnone will be responsible for leading BioreclamationIVT’s communications campaigns and raising awareness of its product portfolio in the life sciences industry. BioreclamationIVT provides biopharmaceutical companies with specialized in […]

The Systemic Lupus Erythematosus (SLE) Market Forecast 2017-2027

May 17, 2017

LONDON, May 17, 2017 /PRNewswire/ —   Revenue Prospects by Product, Molecule Type (Small Molecules, mAbs, Recombinant Proteins), Pharmacological Class (B-Cell Targeting, Interferon Receptor Antagonists, CD Antagonists, Other) and Geography   Systemic Lupus Erythematosus – our new study reveals trends, R&D progress, and predicted revenues Where is the SLE market heading? If you are involved […]

Global Erythropoietin Market Forecast 2017-2027

May 17, 2017

LONDON, May 17, 2017 /PRNewswire/ — Epoetin Alfa, Epoetin Beta, Darbepoetin Alfa, Biosimilars, EPO API Manufacturing The global erythropoietin market is expected to grow at a CAGR of 7.8% in the first half of the forecast period and CAGR of 4.8% in the second half of the forecast period. The market is estimated at $7.9bn […]

Regenerative Medicine Market to Grow Over $53.7 Billion by 2021 With 23.3% CAGR Says a Report at ReportsnReports.com

May 17, 2017

PUNE, India, May 17, 2017 /PRNewswire/ —   Global Regenerative Medicine Market Analysis & Forecast to 2021 report provides a comprehensive overview of the size of the regenerative medicine market, segmentation of the market (stem cells, tissue engineering and CAR-T therapy), key players and the vast potential of therapies that are in clinical trials.   […]

Dr. Reddy’s Laboratories Announces USFDA Approval for the Launch of Doxorubicin Hydrochloride Liposome Injection in the U.S. Market

May 17, 2017

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has received approval from the U.S. Food and Drug Administration (USFDA) to launch Doxorubicin Hydrochloride Liposome Injection, a therapeutic equivalent generic version of Doxil® (doxorubicin hydrochloride liposome injection), for intravenous use, in the United States market. […]

FEEDBACK